Barbara Pfistermeister
- Geriatrics and Gerontology top 2%
- Toxicology top 2%
- Pediatrics, Perinatology and Child Health
- Economics and Econometrics
- Emergency Medical Services top 10%
- Co-authors
- Renke MaasThomas BürkleHarald DormannBettina Plank‐KiegeleFabian MüllerMartin F. FrommKarl‐Günter GaßmannManfred Criegee‐Rieck
- Topics
- Pharmaceutical Practices and Patient Outcomes (14 papers)Pharmacovigilance and Adverse Drug Reactions (11 papers)Patient Safety and Medication Errors (6 papers)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Barbara Pfistermeister
16 papers receiving 311 citations
Peers
Comparison fields: 5 of 76
- Geriatrics and Gerontology 175
- Toxicology 94
- Pediatrics, Perinatology and Child Health 72
- Economics and Econometrics 52
- Emergency Medical Services 52
Countries citing papers authored by Barbara Pfistermeister
This map shows the geographic impact of Barbara Pfistermeister's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Pfistermeister with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Pfistermeister more than expected).
Fields of papers citing papers by Barbara Pfistermeister
This network shows the impact of papers produced by Barbara Pfistermeister. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Pfistermeister. The network helps show where Barbara Pfistermeister may publish in the future.
Co-authorship network of co-authors of Barbara Pfistermeister
This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Pfistermeister. A scholar is included among the top collaborators of Barbara Pfistermeister based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Pfistermeister. Barbara Pfistermeister is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 6 | |
| 3 | 54 | |
| 4 | 6 | |
| 5 | 7 | |
| 6 | 1 | |
| 7 | The effect object paradigm--a means to support medication safety with clinical decision support. | 3 |
| 8 | 23 | |
| 9 | 56 | |
| 10 | 18 | |
| 11 | 68 | |
| 12 | 24 | |
| 13 | 13 | |
| 14 | 1 | |
| 15 | 16 | |
| 16 | 18 |
About Barbara Pfistermeister
Barbara Pfistermeister is a scholar working on Geriatrics and Gerontology, Toxicology and Health Information Management, having authored 16 papers that have together received 316 indexed citations. Recurring topics across this work include Pharmaceutical Practices and Patient Outcomes (14 papers), Pharmacovigilance and Adverse Drug Reactions (11 papers) and Patient Safety and Medication Errors (6 papers). The work is most often cited by research in Geriatrics and Gerontology (175 citations), Toxicology (94 citations) and Family Practice (25 citations). Barbara Pfistermeister has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Renke Maas, Thomas Bürkle, Harald Dormann, Bettina Plank‐Kiegele, Fabian Müller, Martin F. Fromm, Karl‐Günter Gaßmann, Manfred Criegee‐Rieck, Florian Meier and Oliver Schöffski. Their work appears in journals such as PLoS ONE, Clinical Pharmacology & Therapeutics and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.